| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 210.943 | 1.226 | - | 146 | 0 |
| Total Income - EUR | - | - | - | 0 | 0 | 210.943 | 9.270 | - | 28.405 | 0 |
| Total Expenses - EUR | - | - | - | 460 | 25.444 | 161.102 | 18.862 | - | 29.737 | 626 |
| Gross Profit/Loss - EUR | - | - | - | -460 | -25.444 | 49.841 | -9.592 | - | -1.332 | -626 |
| Net Profit/Loss - EUR | - | - | - | -460 | -25.444 | 43.513 | -10.186 | - | -1.332 | -626 |
| Employees | - | - | - | 0 | 1 | 0 | 0 | - | 0 | 0 |
Check the financial reports for the company - Hertz Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 10.790 | 32.658 | - | 0 | 0 |
| Current Assets | - | - | - | 217 | 150.676 | 13.653 | 124.504 | - | 57.017 | 56.686 |
| Inventories | - | - | - | 0 | 143.289 | 2.319 | 108.801 | - | 42.453 | 42.216 |
| Receivables | - | - | - | 0 | 4.347 | 2.668 | 14.725 | - | 10.914 | 10.853 |
| Cash | - | - | - | 217 | 3.040 | 8.666 | 978 | - | 3.650 | 3.617 |
| Shareholders Funds | - | - | - | -353 | -25.790 | 18.253 | 7.663 | - | -3.144 | -3.753 |
| Social Capital | - | - | - | 107 | 105 | 145 | 142 | - | 142 | 141 |
| Debts | - | - | - | 569 | 176.466 | 6.190 | 149.499 | - | 60.162 | 60.439 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Hertz Pharma S.r.l.